XETRA - Delayed Quote EUR

Evotec SE (EVT.DE)

Compare
8.16
+0.11
+(1.37%)
As of 1:10:15 PM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
777,052.00
781,426.00
751,448.00
618,034.00
500,924.00
Cost of Revenue
670,601.00
606,375.00
577,383.00
466,491.00
375,181.00
Gross Profit
106,451.00
175,051.00
174,065.00
151,543.00
125,743.00
Operating Expense
205,170.00
217,548.00
153,215.00
109,864.00
73,943.00
Operating Income
-98,719.00
-42,497.00
20,850.00
41,679.00
51,800.00
Net Non Operating Interest Income Expense
-6,558.00
-2,476.00
-4,814.00
-6,982.00
-7,126.00
Other Income Expense
-96,860.00
-35,620.00
-169,992.00
202,283.00
-18,834.00
Pretax Income
-202,136.00
-80,593.00
-153,957.00
236,980.00
25,840.00
Tax Provision
-30,767.00
3,320.00
21,698.00
21,470.00
19,562.00
Net Income Common Stockholders
-171,370.00
-83,913.00
-175,655.00
215,510.00
6,278.00
Diluted NI Available to Com Stockholders
-171,370.00
-83,913.00
-175,655.00
215,510.00
6,278.00
Basic EPS
-0.97
-0.47
-0.99
1.30
0.04
Diluted EPS
-0.97
-0.47
-0.99
1.30
0.04
Basic Average Shares
177,192.28
176,916.66
176,674.34
166,405.93
153,752.24
Diluted Average Shares
177,553.38
176,916.66
176,674.34
166,405.93
153,752.24
Total Operating Income as Reported
-160,853.00
-47,507.00
20,850.00
40,996.00
48,556.00
Total Expenses
875,771.00
823,923.00
730,598.00
576,355.00
449,124.00
Net Income from Continuing & Discontinued Operation
-171,370.00
-83,913.00
-175,655.00
215,510.00
6,278.00
Normalized Income
-90,189.81
-54,242.90
-20,658.35
38,630.79
12,334.40
Interest Income
3,905.00
9,263.00
8,336.00
2,272.00
1,339.00
Interest Expense
10,463.00
11,739.00
13,150.00
9,254.00
8,465.00
Net Interest Income
-6,558.00
-2,476.00
-4,814.00
-6,982.00
-7,126.00
EBIT
-191,673.00
-68,854.00
-140,807.00
246,234.00
34,305.00
EBITDA
-191,673.00
24,125.00
-57,611.00
316,633.00
90,363.00
Reconciled Cost of Revenue
670,601.00
606,375.00
577,383.00
466,491.00
375,181.00
Reconciled Depreciation
--
92,979.00
83,196.00
70,399.00
56,058.00
Net Income from Continuing Operation Net Minority Interest
-171,370.00
-83,913.00
-175,655.00
215,510.00
6,278.00
Total Unusual Items Excluding Goodwill
-95,755.00
-34,906.00
-182,349.00
194,501.00
-8,652.00
Total Unusual Items
-95,755.00
-34,906.00
-182,349.00
194,501.00
-8,652.00
Normalized EBITDA
-95,918.00
59,031.00
124,738.00
122,132.00
99,015.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-14,574.81
-5,235.90
-27,352.35
17,621.79
-2,595.60
12/31/2020 - 11/12/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

APPH.DE Apontis Pharma AG
10.35
+1.47%
 
DMP.DE Dermapharm Holding SE
40.10
+0.25%
 
SBX.DE SynBiotic SE
4.8700
-1.62%
 
MRK.DE Merck KGaA
145.10
+3.16%
 
29A.SG Amphastar Pharmaceuticals Inc
36.19
-0.74%
 
068760.KQ Celltrion Pharm, Inc.
55,900.00
-0.71%
 
H6D0.DE Haleon plc
4.4390
+0.36%
 
0ET.MU Esperion Therapeutics Inc
2.1980
0.00%
 
SPBBF Speakeasy Cannabis Club Ltd.
0.0000
0.00%
 
ZOE.DE Zoetis Inc.
163.68
+1.07%